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ABSTRACT
Neural stem cells cultured with fibroblast growth factor 2
(FGF2)/epidermal growth factor (EGF) generate clonal ex-
pansions called neurospheres (NS), which are widely used
for therapy in animal models. However, their cellular com-
position is still poorly defined. Here, we report that NS
derived from several embryonic and adult central nervous
system (CNS) regions are composed mainly of remarkable
cells coexpressing radial glia markers (BLBP, RC2,
GLAST), oligodendrogenic/neurogenic factors (Mash1,
Olig2, Nkx2.2), and markers that in vivo are typical of the
oligodendrocyte lineage (NG2, A2B5, PDGFR-). On NS
differentiation, the latter remain mostly expressed in neu-
rons, together with Olig2 and Mash1. Using cytometry, we
show that in growing NS the small population of multi-
potential self-renewing NS-forming cells are A2B5 and
NG2. Additionally, we demonstrate that these NS-form-
ing cells in the embryonic spinal cord were initially NG2
and rapidly acquired NG2 in vitro. NG2 and Olig2 were
found to be rapidly induced by cell culture conditions in
spinal cord neural precursor cells. Olig2 expression was
also induced in astrocytes and embryonic peripheral ner-
vous system (PNS) cells in culture after EGF/FGF treat-
ment. These data provide new evidence for profound
phenotypic modifications in CNS and PNS neural precur-
sor cells induced by culture conditions. STEM CELLS
2007;25:340 –353
INTRODUCTION
Neurospheres (NS) are widely used as a model for studying the
neural lineage in vitro [1, 2]. NS arise from a clonal expansion
of immature cells referred to as NS-forming cells. NS can be
derived from most regions of embryonic nervous tissue and also
from restricted regions of the adult central nervous system
(CNS) (mostly subependymal and hippocampus) [3]. Typically,
NS generate new NS after acute dissociation and reseeding
(passageability), and on growth factor removal and adhesion,
they generate astroglial cells, neurons, and oligodendrocytes
(multipotentiality). However, depending on the stage and on the
CNS region studied, NS multipotentiality and passageability
vary considerably and some NS rapidly lose these properties in
culture [4]. Using this model, neural stem cells (NSC) are
defined as cells able to form NS that retain properties of mul-
tipotentiality and passageability over an unlimited or extended
period [5]. According to these criteria, in the adult rodent CNS,
only the ventricular subependyma appears to contain NSC,
whereas the dentate gyrus contains lineage and differentiation-
restricted cells, referred to as progenitors.
NS have been extensively used as a source of new cells for
therapeutic strategies in mouse models of human nervous sys-
tem diseases. NS cells appear to be endowed with a high
capacity to migrate to lesioned sites and to cross the blood-brain
barrier [6]. Promising results have been obtained in models of
multiple sclerosis, Parkinson’s disease, brain tumors, and spinal
cord lesions. However, the mechanisms whereby NS cells pro-
vide therapeutic benefits are still unclear. In addition to replac-
ing lost cells, neural precursor cell transplantation appears to be
able to reduce glial scar [6], to rescue dysfunctional neurons
probably through the release of trophic factors [7], and to recruit
endogenous neural precursor cells for regeneration [6]. Re-
cently, NS cells have also been shown to induce apoptosis of
CNS-infiltrating T cells [8].
The identity of the NS-forming cells has been partially
elucidated in adult CNS. In the brain, both glial fibrillary acidic
protein-positive (GFAP) cells and type-C cells (NG2/Dlx-
2) located in the subependymal zone can form NS [9–11], but
their long-term passageability has been thoroughly studied for
GFAP cell-derived NS only. Apart from the neurogenic re-
gions, some A2B5 cells located in the human subcortical white
matter are also endowed with the capacity of generating pas-
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sageable multipotential NS [12]. More recently, postnatal brain
microglial cells have been shown to form multipotential NS-like
structures, but the very high serum concentration needed to
produce these NS, questions the physiological relevance of this
observation [13]. The identity of the NS-forming cells, in con-
trast to postnatal CNS, in the embryo is largely unknown.
The NS cellular composition is still unclear. They appear to
be heterogeneous entities containing a majority of poorly de-
fined neural immature cells, unable to form new NS, and only a
small fraction of multipotential self-renewing NS-forming cells
(0.1%–10%). The majority of NS cells express markers of radial
glial cells (RC2, GLAST, BLBP) [14–16]. The latter are known
to provide a transient scaffold for neuronal cell migration during
development, and more recent data indicate that they also serve
as neuronal progenitors in all regions of the CNS [17]. However,
the radial glia cell population appears to be heterogeneous
within and between different brain regions [18]. Indeed, these
cells differ in their expression of growth factors and transcrip-
tion factors and in the cell types they generate. With regard to
this in vivo heterogeneity, very few data are available on the
phenotype of radial glial cells contained in NS.
Finally, there is an ongoing debate about the physiological
relevance of the NS model for studying the diversity, phenotype,
and fate of neural precursor cells present during CNS develop-
ment. Several studies indicate that regional specifications and
intrinsic differences are maintained in NS cultures even at late
passages [19–22]. In contrast, other data argue for the existence
of deregulations in the differentiation potential and spatial iden-
tity of neural precursors grown in NS in the presence of high
concentrations of growth factors [23–26].
Considering their high therapeutic potential and their broad
use as a model of neural development, it is essential to better
characterize the identity of NS-forming cells (both in vivo and
in vitro) and NS cellular composition. Here, we further explore
the phenotype of embryonic NS-forming cells and the cellular
composition of NS derived from different CNS regions. We
focused our analysis on the expression of markers that are
relatively specific for the oligodendrocyte lineage in vivo
(A2B5, platelet-derived growth factor receptor [PDGFR]-,
NG2) and on important neural precursor cell fate-determining
transcription factors (Olig2, Mash1, Sox 9, Sox10, Nkx2.2). We
found that regardless of their origin, NS contain remarkable
cells coexpressing A2B5, PDGFR-, NG2, Olig2, Sox9, and
radial glia markers (RC2, BLBP, GLAST). Using cytometry and
clonal analysis, we investigated whether NS-forming cells con-
tained in NS were NG2 and A2B5 and whether these cells
were originally derived from NG2 or NG2 cells in the
embryonic neural tube. The possibility of the direct implication
of the basic helix-loop-helix (bHLH) genes (Olig2 and Mash1)
in the expression of NG2 in neural precursors was explored. Our
data provide evidence that NS are initially derived from NG2
NSC that subsequently generate NG2 NSC and that profound
phenotype deregulations are likely to occur in CNS and also in
peripheral nervous system (PNS) neural precursors cultured in
NS culture conditions.
MATERIALS AND METHODS
Dissection and Cell Isolation
For information regarding dissection and cell isolation, see the
supplemental online data.
Cell Culture
For NS cultures, acutely dissociated cells were cultured at 37°C at
100 cells per microliter (equivalent to 20,000 cells per cm2) in
75-cm2 tissue culture flasks (NUNC A/S, Roskilde, Denmark,
http://www.nuncbrand.com) coated with 400 g/cm2 poly-2-hy-
droxyethyl-methacrylate (poly-HEME) (Sigma-Aldrich, St. Louis,
http://www.sigmaaldrich.com) to prevent cell attachment. To exam-
ine the phenotype and fate of clonal NS after passaging, the cells
were seeded at 2–5 cells per microliter (equivalent to 250–600 cells
per cm2) to allow clonal expansion [27]. The medium consisted of
N2 supplement (Invitrogen Corporation, Carlsbad, CA, http://www.
invitrogen.com), 2 mM L-glutamine (Invitrogen Corporation), 0.6%
glucose (Sigma-Aldrich), 20 g/ml bovine insulin (Sigma-Aldrich),
and 2 g/ml ciprofloxacine (United States Biological Inc., Swamp-
scott, MA, http://www.usbio.net) in Dulbecco’s modified Eagle’s
medium/F-12 medium (Invitrogen Corporation) supplemented with
20 ng/ml epidermal growth factor (EGF) (PeproTech, Rocky Hill,
NJ, http://www.peprotech.com) and 10 ng/ml fibroblast growth
factor 2 (FGF2) (PeproTech). NS were passaged every 7 days by
incubation in 0.25% trypsin/1 mM EDTA (Invitrogen Corporation)
(3 minutes, 37°C). The cells were mechanically dissociated in the
presence of 2 mM CaCl2, 0.01% DNase I, and 0.5% soybean trypsin
inhibitor and then rinsed once with medium. Embryonic dorsal
spinal cord cells (Fig. 1C; supplemental online Fig. S3) were plated
with or without FGF2/EGF at 50,000 cells per cm2 either on
poly-D-lysine (PDL)-coated (adherent condition) or in poly-HEME-
coated (non adherent condition) coverslips. For differentiation ex-
periments, NS were rinsed twice with Hanks’ balanced salt solution
(HBSS) (Invitrogen Corporation), enzymatically dissociated, and
plated on coverslips coated with 40 g/ml PDL (Sigma-Aldrich) for
4 days at 250,000 cells per cm2 in 24-well dishes without FGF2 and
EGF. Alternatively, to analyze the multipotency of clonally ex-
panded NS, single spheres (size 300–500 m) were harvested under
the microscope, individually plated on coverslips, and allowed to
differentiate for 4–6 days before processing for triple-labeling.
MHP36 Cell Culture and Transfection
This NSC line (a gift from Dr. J. Sinden, London) [28] was cultured
as described previously [29] at 37°C at a density of 10,000 cells per
square centimeter in 75-cm2 tissue culture flasks coated with 10
g/ml fibronectine (Sigma-Aldrich). This cell line is conditionally
immortalized by a thermolabile form (ts58) of SV40 TAg, the
expression of which is controlled by the interferon-regulable H-2Kb
promoter. At 37°C, the ts58 TAg is not active and the cells adopt a
wild-type phenotype with regard to growth and differentiation [28].
The culture medium was the same as for NS but was supplemented
with 10 ng/ml FGF2 (PeproTech), 2 g/ml heparin (Sigma-Al-
drich), and 1 ng/ml interferon- (PeproTech). For passaging, cells
were incubated for 15 minutes with Versene (Invitrogen Corpora-
tion). Transfection experiments were carried out without interfer-
on- and at 37°C (nonimmortalized conditions). Plasmid transfec-
tion was performed using Effectene Transfection Reagent (Qiagen
Inc., Valencia, CA, http://www1.qiagen.com). Plasmids pcDNA3,
pcDNA3 mOlig2 (Dr. H. Takebayashi, Kyoto, Japan) [30], peGFP
(Dr. S.F. Heinemann, San Francisco, California), and pcDNA1
Mash1 (Dr. F. Guillemot, London) were prepared using the End-
oFree Plasmid Maxiprep Kit (Qiagen Inc.). Cells were tested for
NG2 and PDGFR- expression 48 hours after transfection.
Immunodetection
Immunodetection was carried out as described in [15] on cells fixed
for 15 minutes at room temperature with 4% paraformaldehyde. For
surface antigen labeling (O4, GalC, A2B5), Triton was omitted; for
multilabeling including both surface and intracellular markers,
0.01% Triton was used. Cells freshly dissociated from tissues or
small NS were stuck on poly-L-ornithine-coated coverslips by cen-
trifugation (10 minutes, 1,000 rpm) in 24-well dishes and immedi-
ately fixed. For large NS, 12-m-thick frozen sections were made
from fixed NS, incubated in 25% sucrose (overnight 4°C), and
embedded in OCT (Tissue-Tek, Torrance, CA, http://www.sakura-
americas.com). For embryonic frozen sections, E13.5 embryos were
fixed in 4% paraformaldehyde for 6 hours and cryoprotected by
incubation successively for 2 hours in 12%, 15%, and 18% sucrose
solutions in phosphate-buffered saline (PBS), overnight in 25%, and
for 2 hours in 25% sucrose in OCT. They were embedded in pure
OCT and frozen in cold isopentane in liquid nitrogen. The primary
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Figure 1. Induction of Olig2 by culture condition. (A): Olig2 immunodetection on 12-m-thick cryostat section of embryonic day 13.5 (E13.5)
thoracic spinal cord and dorsal root ganglia (DRG). Left photograph: low-magnification image of section stained with Hoechst (gray). Scale bar 
100 m. Middle and right photographs: High-magnification images of DRG (red square on left photograph) and ventral part of the neural tube (yellow
square on left photograph). Olig2 (green) is expressed only in ventrally located cells in the spinal cord. Scale bar  50 m. (B): Time-course
expression of Olig2 in E13.5 embryonic spinal cord cultures. Protocol is identical to that described in Figure 4F legend. The percentage of Olig2
cells  SEM (n  3 independent experiments) in the cellular suspension is indicated from days 0 to 7. (C): Time-course expression of Olig2 in dorsal
E13.5 embryonic spinal cord cultures. Cells were cultured on poly-D-lysine with () or without (-) growth factor (GF) at a density of 50,000 cells
per square centimeter. The number of Olig2 cells per field (20 objective) is indicated  SEM (n  3 independent experiments). (D): Expression
of Olig2 in astrocytes. Control: Upon NS differentiation, GFAP (green) cells (arrow) are Olig2 (red). After 24-hour reintroduction of FGF2/EGF,
the vast majority of GFAP cells display a strong Olig2 staining. Scale bar  10 m. (E): RC2 immunodetection on 12-m-thick cryostat section
of E13.5 thoracic spinal cord (SP) and DRG. Left photograph: section stained with Hoechst (gray). Right upper photograph: RC2 staining (green).
Note the elongated radial glia cells (arrow). Green staining in the DRG (arrowheads) is not specific and is also detected in red with cyanine 3-filtered
light (supplemental online Fig. S7). Scale bar  100 m. (F): Detection of Olig2 (upper photograph, red) and RC2 (lower photograph, green) in E13.5
peripheral nervous system (PNS) cells cultured 10 days in NS media. Nuclei are stained with Hoechst (right photographs). Scale bar  10 m. (G):
Phenotype of NS derived from E13.5 embryonic PNS. Photographs are confocal images of NS immunolabeled with the indicated marker. Scale bars 
10 m. Dotted circle indicates NS outline. (H): Immunodetection of cells expressing smooth-muscle actin (green, arrows on right photographs) in
differentiated embryonic NS (upper photographs) and PNS NS (lower photographs). Nuclei are stained with Hoechst (blue). (I): Triple-immunos-
taining of MHP36 cells transfected with both Olig2 and Mash1 plasmids revealed that Mash1 (red) and Olig2 (green) are not sufficient to induce NG2
expression (far-red). Nuclei are labeled with Hoechst (blue). Scale bar  10 m. Abbreviations: EGF, epidermal growth factor; FGF2, fibroblast
growth factor 2; GFAP, glial fibrillary acidic protein.
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antibodies used are provided in the supplemental online data. Neg-
ative controls were performed using isotype-matched immuno-
globulins (Sigma-Aldrich). Nuclei were stained with either 5 g/ml
Hoechst 33242 solution (Sigma-Aldrich) or 1 g/ml propidium
iodide solution (Sigma-Aldrich). Slides were observed using a Leica
DMR fluorescence microscope (Leica, Wetzlar, Germany, http://
www.leica.com) or a confocal scanning Zeiss axiovert 100TV in-
verted microscope (Carl Zeiss, Jena, Germany, http://www.zeiss-
.com) equipped with a Bio-Rad MRC 1024 laser (Bio-Rad
Laboratories, Inc., Hercules, CA, http://www.bio-rad.com). At least
300 cells were counted for each staining.
RNA Isolation and Reverse Transcription-
Polymerase Chain Reaction
Total RNAs were extracted from murine undifferentiated NS using
the RNeasy Mini Kit (Qiagen Inc.). Reverse transcription-poly-
merase chain reaction (RT-PCR) was performed as described in
[15]. Primers were designed using the Primer3 software (Qiagen
Inc.). Each PCR was performed in parallel with RT() samples in
which the reverse transcriptase was omitted to check that the am-
plified product was not derived from genomic DNA. -Actin am-
plification was used as an internal positive control. A PCR ampli-
fication was considered positive if a unique band at the exact size
was obtained. Primer sequences, expected size, and details of am-
plification conditions are provided in the supplemental online data.
Flow Cytometry
For cell sorting, NS were harvested by centrifugation, incubated in
HBSS without Ca2 and Mg2 (HBSS) (15 minutes, 37°C),
mechanically dissociated with a yellow tip, and rinsed in HBSS.
The cell suspension (approximately 20  106 cells) was incubated
(15 minutes, 4°C) with the primary antibodies (NG2 [1:500], A2B5
[1:500]) or control antibodies to obtain the background fluorescence
(rabbit IgG for NG2; IgM for A2B5) diluted in 0.5% PBS-bovine
serum albumin (BSA) (crystalline bovine albumin; Invitrogen Cor-
poration). Cells were rinsed in HBSS and then incubated (15
minutes, 4°C) with secondary antibodies (1:400; goat anti-rabbit
IgG Alexa Fluor 488 or goat anti-mouse IgM Alexa Fluor 488;
Invitrogen Corporation). Cells were rinsed in HBSS and resus-
pended in 2 g/ml propidium iodide. To sort cells from embryonic
day 13.5 (E13.5) spinal cord, approximately 20 embryos were
dissected. Spinal cord cells were mechanically dissociated using a
yellow tip, passed through a 40-m strainer to obtain a single cell
suspension, and rinsed with HBSS to eliminate cell debris. Label-
ing was performed as described above. Cell sorting was performed
using a FACSVantage SE Turbosort (BD Biosciences, San Jose,
CA, http://www.bdbiosciences.com) equipped with a 488 nm Laser
Sapphire 488-20. A red fluorescence (for propidium iodide) and a
size threshold were used to eliminate dead cells and cellular debris.
Cells were collected in PBS or in NS medium. After cytometry,
cells were directly seeded in 25-cm2 flasks to allow NS formation at
clonal density (five cells per microliter, equivalent to 600 cells per
cm2). The total number of NS formed was assessed 10 days later by
carefully scanning the entire flask with a binocular microscope.
RESULTS
NS Are Composed Mainly of Radial Glial Cells
Expressing NG2, A2B5, PDGFR-, and Sox9
NS derived from adult and embryonic CNS are composed of
cells expressing radial glial markers (BLBP, RC2, and GLAST).
On differentiation, these NS generate mainly astroglial cells,
whereas neuronal cells and oligodendrocytes account for only a
small percentage of cells (typically 1%–10%) [15, 26]. The
phenotype of NS cells was further analyzed by examining
markers that are relatively specific for oligodendrocyte precur-
sors in vivo (i.e., NG2 [31], A2B5 [32], and PDGFR- [33]),
although these markers have also been reported to be expressed
by other cell types, especially in vitro. In addition, we examined
the expression of the oligodendrocytic lineage markers CNPase,
Nkx2.2 [34], Sox10 [35], and Sox9. The latter is expressed by
neuroepithelial cells at the onset of gliogenesis and is a major
molecular component in determining their glial fate [35]. NS
were derived from E13.5 embryonic spinal cord and passaged
four times to avoid any potential contamination with nonprolif-
erative cells. The phenotype of NS expanded for 4 days under
clonal conditions (sphere size: approximately 10 cells) was then
examined by immunofluorescence. Surprisingly, we found that
all spheres derived from embryonic spinal cord displayed a
broad expression of the three markers NG2, A2B5, and
PDGFR- (Fig. 2A, 2F). A more detailed examination indicated
that within spheres, nearly all cells were positive for these three
markers (Fig. 2B). Immunodetection performed on dissociated
NS revealed that 95%  5% (n  3) cells expressed PDGFR-,
which (as observed in other cell types [36]) appeared to be
mainly cytoplasmic. Sox 10 and CNPase expression was not
detected in undifferentiated NS. In contrast, Nkx2.2 was ex-
pressed by a significant number of cells (between 10% and
30%) in all NS (supplemental online Fig. S1) and the majority
of NS cells were strongly positive for Sox9 (supplemental
online Fig. S1). Interestingly, in NS cells, this transcription
factor was confined mainly to the cytoplasm as observed by
others during gonad development [37]. We further quantified
the broad expression of the A2B5 and NG2 on NS cell surfaces
by flow cytometry analysis (Fig. 2C) (NG2 cells: 78%  4%,
n  4; A2B5 cells: 94%  3%, n  6). The presence of NG2
and PDGFR- was confirmed at the mRNA level by RT-PCR
(Fig. 2D). NS contained a small proportion of GFAP cells
(9.8%  4%, n  5) and most of them (89%  4%, n  5) were
found to strongly express NG2 (Fig. 2E).
As a comparison, we derived NS from E13 embryonic
cortex, striatum, and adult spinal cord and examined their phe-
notype. Regardless of their origin, all NS strongly expressed
A2B5, NG2, and PDGFR- (Fig. 2F). Fluorescence-activated
cell-sorting analysis of NS cells derived from embryonic stria-
tum confirmed that more than 80% of cells were NG2.
The phenotype of larger embryonic spinal cord NS (100–
500 m), which had been expanded for 2 weeks and contained
several hundred cells, was also examined (Fig. 2G). To avoid
artifacts due to limited antibody penetration, the spheres were
embedded and sliced before staining. Like small spheres, all
large spheres contained a majority of cells expressing NG2,
A2B5, and PDGFR- (data not shown). However, heterogeneity
was evident as patches of NG2 cells were apparent in some NS
(Fig. 2G). These NG2 cells often colocalized with GFAP
staining, suggesting that astroglial differentiation occurs in the
large spheres. To ascertain that the wide expression of the
markers NG2, A2B5, and PDGFR- was not transient, E13.5
spinal cord-derived NS were cultured for up to 16 passages
(approximately 3 months). The phenotype of these long-term
cultured NS cells appeared to be identical to that of NS that had
been passaged four times (data not shown). To more precisely
define the identity of cells expressing NG2, colabeling was
carried out with markers typical for radial glial cells (BLBP,
RC2, GLAST). As shown in Figure 2H and 2I, we found that in
embryonic spinal cord NS, the vast majority of cells expressing
NG2 were also positive for BLBP, GLAST, and RC2. Identical
results were obtained with NS derived from adult spinal cord
and embryonic striatum (data not shown). In summary, this
phenotypic analysis indicates that NS are composed mainly of
remarkable radial glial cells expressing NG2, A2B5, PDGFR-,
and Sox9 and partly Nkx2.2.
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A2B5, NG2, and PDGFR- Expression Persists in
Neuronal Cells after NS Differentiation
We next examined the evolution of the NG2, A2B5, and
PDGFR- markers when embryonic spinal cord NS were al-
lowed to differentiate. After plating on an adhesive substrate and
in absence of growth factors, these NS typically generate 5%–
10% neurons, 80% astroglial cells, and 1%–5% oligodendro-
cytes, which were detected by 3-tubulin, GFAP, and O4 stain-
ings, respectively [15]. Double-labelings were carried out with
Figure 2. Characterization of neurospheres (NS) cells. (A): Immunolabeling of 4-day-expanded clonal NS derived from embryonic day 13.5 (E13.5)
mouse spinal cord. All NS are stained for NG2, A2B5, and PDGFR- (green). Nuclei (blue) are stained with Hoechst. Scale bar  100 m. (B): At
higher magnification, A2B5 (red), NG2 (green), and PDGFR- (green) antibody stained the majority of cells within NS. Nuclei are labeled with
Hoechst (blue) or propidium iodide (red). NG2 and PDGFR- stainings are confocal photographs. Scale bar  10 m. (C): Flow cytometry analysis
of NS cells revealed that most NS cells express NG2 and A2B5. Diagrams represent the number of cells (counts) versus the levels of fluorescence
(FL1-H) using control nonimmune antibodies (immunoglobulin G [IgG], IgM) or NG2/A2B5 antibodies. Green arrow delimits the highly fluorescent
cell fraction used for assessing NS formation from A2B5 and NG2 cells (Fig. 4A and text). Red arrow delimits the NG2 fraction used for
cytometry in Figure 4A. (D): Detection of NG2 and PDGFR- mRNA expression in NS cells by reverse transcription-polymerase chain reaction
analysis. Reverse transcriptase was omitted (-) in control experiment. (E): A GFAP (green) cell (arrow) expressing NG2 (red). In this experiment,
small NS (10–20 cells) were mechanically dissociated before plating and fixation. Scale bar  10 m. (F): Percentage of embryonic or adult-derived
NS expressing the indicated markers. This experiment is representative of two experiments. (G): NG2 (green) and GFAP (red) double-labeling of
12-m-thick cryostat sections of 2-week-expanded NS. Stainings were analyzed by confocal microscopy. Scale bar  50 m. (H): Double-labeling
of dissociated NS cells with NG2 (green) and radial glial cell markers (red): GLAST, RC2, and BLBP. Scale bar  10 m. (I): Percentage of NG2
cells immunoreactive for BLBP, RC2, and GLAST in growing NS. Values are means  SEMs of three independent cultures. Abbreviations: bp, base
pair; GFAP, glial fibrillary acidic protein; PDGFR, platelet-derived growth factor receptor.
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these markers and A2B5, PDGFR-, and NG2. Surprisingly,
most NG2 cells (approximately 90%) coexpressed 3-tubulin
(Fig. 3A, 3C), whereas less than 1% of NG2 cells coexpressed
the astrocytic marker GFAP or the oligodendrogenic markers
O4 and CNPase (Fig. 3B, 3C). The same NG2 profile was
observed with differentiated NS derived from embryonic stria-
tum (Fig. 3C). The neuronal phenotype of NG2 cells was
confirmed by colabeling these cells with additional neuronal
markers, namely Map2ab, NeuN, and -internexin (Fig. 3A,
3C). Similarly to NG2 detection, PDGFR- and A2B5 detection
was associated mainly with cells expressing neuronal markers
such as 3-tubulin and Map2ab after differentiation and not
with cells expressing the glial markers GFAP, O4, or GalC (Fig.
3D–3F). Of note, in addition to neurons, strong staining for
A2B5 was observed in apoptotic cells that are common after NS
differentiation (Fig. 3E, arrowhead). Given that in the undiffer-
Figure 3. Expression of A2B5, NG2, and PDGFR- in neuronal cells after differentiation. (A): Double-immunostaining of differentiated
neurospheres (NS) revealed that NG2 cells (green) coexpressed (arrows) several neuronal markers 3-tubulin (red), Map2ab (red), NeuN (red), and
-internexin (red). (B): Double-immunostaining of differentiated NS revealed that NG2 cells (green) did not coexpress GFAP (red) or O4 (red). (C):
Percentage of NG2 cells  SEM (n  3) coexpressing astrocytic marker (GFAP), oligodendrogenic markers (O4 and CNPase), and neuronal marker
(3-tubulin, Map2ab, NeuN, and -internexin) in differentiated embryonic spinal cord (upper histograms) and embryonic striatum (lower histograms)
NS cells. (D): Double-immunostaining of differentiated spinal cord NS cells revealed that PDGFR- cells (green) coexpressed (arrows) 3-tubulin
(red) and Map2ab (red), but not GFAP (red) or O4 (red). Nuclei are labeled with Hoechst (blue). (E): Double-immunostaining of differentiated NS
cells revealed that A2B5 cells (green) coexpressed (arrows) 3-tubulin (red) and Map2ab (red), but not GFAP (red) or GalC (red). Note that most
dead cells, displaying a typical apoptotic nucleus, also stained for A2B5 (arrowhead). Nuclei are labeled with Hoechst (blue). (F): Percentage of
A2B5 cells and PDGFR- cells  SEM (n  3) coexpressing differentiated cell markers. Scale bars  10 m. Abbreviations: GFAP, glial
fibrillary acidic protein; PDGFR, platelet-derived growth factor receptor.
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entiated state, NG2, A2B5, and PDGFR- were found to be
expressed by the majority of NS cells, whereas after differenti-
ation their expression is restricted to the small neuronal popu-
lation (less than 10%), these results are indicative of their
downregulation in glial cells after differentiation.
NS-Forming Cells in NS Expressed NG2
and A2B5
NS typically contain only a small population (1%–10% for
embryonic spinal cord NS [15]) of NS-forming cells able to
form new passageable and multipotential NS after dissocia-
tion and reseeding. We questioned whether these cells ex-
press NG2. Because there is no specific marker for the
NS-forming cells present in NS, it was not possible to ex-
amine directly whether they expressed NG2. To overcome
this problem, we tested whether NG2 cytometry-purified
cells from NS were able to form new NS. Because the number
of NS-forming cell is low, we first examined the accuracy of
NS cell sorting by using cytometric analysis. We derived
embryonic spinal cord NS from actin promoter-green fluo-
rescent protein (GFP) transgenic mice [38] (supplemental
online Fig. S2). After four passages, cells were dissociated,
mixed 50:50 with nontransgenic NS cells, and allowed to
grow for 7 days. Cells were then sorted for negative and
positive GFP expression (supplemental online Fig. S2) and
allowed to form NS at clonal density for 10 days. All ob-
served NS (129/129) derived from GFP-sorted cells were
GFP, and 151/152 NS derived from the GFP fraction were
GFP. This demonstrates that the cellular contamination
between fractions in our cytometric analysis was below 1%,
thus validating this approach for analyzing the phenotype of
NS-forming cells. We then established that dissociated NS
cells, incubated with control nonimmune IgG and processed
for cytometric analysis, generated new NS at an NS-forming
rate (nsfr) of 7.6%  0.2% (n  5) (Fig. 4A). In a parallel
experiment, dissociated NS cells were incubated with NG2
and strongly NG2 fluorescent (55% of cells; green arrow-
delimited cell fraction on Fig. 2C) and NG2 cells (2.6% of
cells; red arrow-delimited cell fraction) were sorted and
allowed to form NS at clonal density. NG2 cells formed NS
at a rate equivalent to IgG control: nsfr  7.0%  0.3% (n 
5) (Fig. 4A). In contrast, NG2 cells showed an nsfr of only
0.6%  0.2% (n  2). To confirm that NS generated from the
NG2 fraction are truly derived from NG2 cells, we sub-
mitted the NG2 fraction to a second round of cytometry.
These NG2 double-sorted cells show the same nsfr as that
of double-sorted control IgG-incubated cells (Fig. 4A). The
similar decrease of the nsfr observed in both double-sorted
NG2- and IgG-incubated cells is likely due to a reduction of
cellular viability induced by the second cytometry. To check
that the NG2 cell-derived NS were passageable and multi-
potent, these were cultured for five passages, allowed to
differentiate, and processed for triple-labeling. Of the more
than 50 NS tested, all were multipotent as indicated by the
presence of Map2ab neurons, GFAP astrocytes, and O4
oligodendrocytes (Fig. 4B). Because NS are composed of a
majority of NG2 cells and because these cells have an nsfr
equivalent to that of the whole NS cell population (in contrast
to NG2 cells), we conclude that the majority of multipo-
tential and self-renewing NS-forming cells in NS are NG2.
Using a similar analysis with A2B5 marker (green arrow-
delimited cell fraction on Fig. 2C), we found that that the vast
majority of NS-forming cells express this marker (not
shown).
NS Are Derived from NG2 Cells in the Embryonic
Spinal Cord
Having established in NS the expression of NG2 in radial glia
cells and NS-forming cells, we then examined the in vivo
situation. The expressions of RC2 and NG2 markers were
examined on E13.5 spinal cord slices (Fig. 4C). As expected,
RC2 mainly stained cells with a radial morphology. In con-
trast, as observed by others at this stage of development, NG2
was barely expressed and the staining was associated mainly
with vessels [39, 40]. The sparse expression of NG2 was
confirmed by flow cytometry, showing that in acutely disso-
ciated spinal cord, only 1%  0.3% (n  11) of cells were
NG2 (Fig. 4D, blue arrow-delimited fraction). We also
examined the presence of A2B5, but its expression pattern
was more complex, and in contrast to NG2, a considerable
number of cells appeared positive (data not shown and [39]).
The clear difference between the expression of NG2 in RC2
radial glial cells in vivo and in vitro led us to formulate two
alternative hypotheses. (a) Because in postnatal CNS some
NG2 cells are able to form multipotent NS [41] and because
in vitro the growth factors FGF2/EGF can induce the expres-
sion of the radial glial markers RC2 and BLBP in neuroep-
ithelial cells or even in NS-derived differentiated cells [15,
16, 42], one can consider that embryonic spinal cord NS
originate from the resident nonradial glial NG2 cells that
would acquire RC2 and BLBP expression in vitro. (b) Alter-
natively, NS could be derived from resident NG2 cells, and
NS cells would acquire NG2 in cell culture. To distinguish
between these hypotheses, two experiments were performed.
First, to test whether NG2 expression could be induced by the
cell culture conditions, we seeded dissociated E13.5 spinal
cord cells in the presence of FGF2/EGF and monitored NG2
expression in these cells for a period of 7 days. As shown in
Figure 4E and 4F, immediately after dissection, less than 1%
of cells were NG2, but after 7 days in culture, approxi-
mately 50% of the cells were positive. As observed by others
[43], these data support an induction of NG2 under the
culture conditions. In a second experiment, we sought to
establish whether NS-forming cells in the E13.5 embryonic
spinal cord were NG2 or NG2 by using a cytometric
approach. We first established that the nsfr of E13.5 embry-
onic cells incubated with IgG and passed through the cytom-
eter is 0.1  0.03% (n  5) (Fig. 4G). In a parallel experi-
ment, cells were incubated with NG2 antibody, and NG2
and NG2 fractions were sorted (delimitations are indicated
in Fig. 4D) and allowed to form NS at clonal density. As
shown in Figure 4G, NG2 cells have the same nsfr as the
cells incubated with IgG. With regard to the NG2 fraction,
the small percentage of NG2 cells in the spinal cord (1%)
combined with the high rate of cell death associated with
cytometry did not allow us to accurately determine their nsfr.
NS were occasionally observed within this fraction, and the
nsfr was estimated to lie between 0.02% and 0.001%. To
further establish that the NS-forming cells are within the
NG2 population, this fraction was passed again through the
cytometer and the nsfr was compared with that of cells
incubated with IgG and double-sorted. Figure 4G indicated
that the nsfr of double-sorted NG2 is the same as that of
IgG-incubated cells. As previously mentioned, after the sec-
ond cytometry, we observed a reduction in nsfr both in IgG-
and NG2-incubated cells, probably due to the harsh condi-
tions of cytometry. This decrease was more abrupt than for
NS cells, probably because primary embryonic spinal cord
cells are more fragile. After 7 days, NS derived from the
NG2 fraction were analyzed by immunofluorescence (Fig.
4H, right). Thirty-two out of 32 analyzed NS were strongly
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NG2, and all cells appeared to be positive. As observed in
NS derived from the whole spinal cord cell population,
NG2 cell-generated NS could be propagated for at least five
passages and were multipotent as assessed by differentiation
and triple-labeling (not shown). After five passages, these NS
were still composed of NG2 cells (not shown). To further
Figure 4. Acquisition of NG2 expression in vitro. (A): Neurospheres (NS)-forming rate (nsfr) of NG2-, NG2-, and immunoglobulin G
(IgG)-sorted cells derived from embryonic day 13.5 (E13.5) embryonic spinal cord NS after one or two cycles of cytometry. The collected NG2 and
NG2 fractions are indicated in Figure 2C. This experiment is representative of three independent experiments. (B): Example of a triple-
immunostaining carried out on a differentiated NS generated from clonal expansion of NG2 cells sorted from NS. Multipotentiality is demonstrated
by the presence of Map2ab (red), GFAP (green), and O4 (blue) cells. Scale bar  10 m. (C): Immunostaining of 12-m-thick cryostat sections
of E13.5 mouse thoracic spinal cord with NG2 (left, green) and RC2 (right, green). NG2 staining is associated mainly with vessels, whereas RC2
stained radial glia cells. Nuclei are labeled with Hoechst (blue). Scale bar  100 m. (D): Flow cytometric analysis of freshly dissociated E13.5 spinal
cord cells labeled with IgG and NG2 antibody. Diagrams represent the number of cells (counts) versus the levels of fluorescence (FL1-H). The NG2
cell fraction (area delimited by red arrows) and the NG2 cell fraction (delimited by blue arrows) were sorted out separately and used in (G).
Fluorescence background was set using spinal cord cells labeled with nonimmune IgG (left). (E, F): Time-course expression of NG2 in E13.5
embryonic spinal cord culture. Cells from freshly dissected spinal cords were directly plated and fixed (day 0 [D0]) or seeded at 400 cells per microliter
in FGF2/EGF-containing NS media on poly-2-hydroxyethyl-methacrylate-coated T25. An aliquot of the cellular suspension was collected at days 1,
4, and 7, mechanically dissociated, plated, and stained for NG2. (E): Example of NG2 cells (green) present in the cellular suspension at D0 and D7.
Nuclei are labeled with Hoechst (blue). Scale bar  20 m. (F): Percentage of NG2 cells  SEM (n  3 independent experiments) in the cellular
suspension at the indicated day. (G): nsfr of NG2- and IgG-sorted cells (one and two cycles of cytometry) derived from freshly dissociated E13.5
embryonic spinal cord. The NG2 and NG2 fractions are delimited in (D). This experiment is representative of three experiments. (H): NG2
immunolabeling (green) of NS derived from E10 (left) or E13.5 (right) spinal cord NG2-sorted cells. Most, if not all, cells are NG2. Nuclei are
labeled with Hoechst (blue). Scale bar  10 m. Abbreviations: EGF, epidermal growth factor; FGF2, fibroblast growth factor 2; GFAP, glial
fibrillary acidic protein.
347Dromard, Bartolami, Deleyrolle et al.
www.StemCells.com
confirm that NS originate from NG2 cells, we derived NS
from E10 spinal cord. At this stage of development, NG2 is
not expressed (our own data and [39, 44]). After 5 days, E10
NS were examined for NG2 expression and 34/34 showed
intense NG2 labeling (Fig. 4H, left). These results indicate
that at E10 and E13.5, NS are derived from NG2 embryonic
NSC that rapidly acquire this marker in vitro.
Expression of Olig2 and Mash1 in Growing and
Differentiated NS
The detection in NS cells of markers typically associated with
the oligodendrogenic lineage in vivo prompted us to analyze the
expression of bHLH transcription factors known to be important
for oligodendrocyte formation (Olig1, Olig2, and Mash1) [30,
45–47]. By means of RT-PCR analysis, mRNAs for these genes
were detected in embryonic spinal cord NS (Fig. 5A). By means
of immunodetection in NS cells, no convincing Olig1 staining
was obtained, but Olig2 and Mash1 proteins were readily de-
tected. In small NS (2–4 days of growth), most if not all cells
were found to be positive for Olig2 and Mash1 (Fig. 5B). As
spheres became larger (10 days of growth), Olig2 was still
widely expressed whereas Mash1 expression appeared hetero-
geneous and negative cells were apparent (Fig. 5B). Olig2 and
Mash1 expression was also examined after NS differentiation
(Fig. 5C, 5E). The GFAP astrocytes were negative for Olig2,
whereas (as expected) 75% of the O4 oligodendrogenic cells
strongly expressed Olig2 (Fig. 5C). Surprisingly, the vast ma-
Figure 5. Expression of oligodendrogenic/neurogenic transcription factors in growing and differentiated neurospheres (NS). (A): Olig1, Olig2, and
Mash1 mRNA expressions were detected in NS cells by reverse transcription-polymerase chain reaction analysis. Reverse transcriptase was omitted
(-) for negative control. (B): Immunostaining of Mash1 (green) and Olig2 (green) in NS (confocal microscopy). Nuclei are stained with propidium
iodide (PI) (red). Upper photographs show small NS (4 days old). Most, if not all, NS cells expressed Olig2 (green) and Mash1 (green). Scale bar 
10 m. Lower photographs show large NS (2 weeks old). Mash1 and Olig2 stainings are merged with red nucleus staining. Olig2 staining appears
homogenous whereas Mash1 is expressed by a subset of cells. Scale bar  25 m. (C): Double-immunostaining of differentiated NS cells revealed
that Olig2 cells (red) coexpressed O4 (green), Map2ab (green), and 3-tubulin (green) but not glial fibrillary acidic protein (GFAP) (green). For the
3-tubulin staining, left and right photographs show Hoechst and Olig2 stainings, respectively. Scale bar  20 m. (D): Example of a Map2ab
(green) cell (arrow, left panel), derived from embryonic striatum NS, with an Olig2 (red, right) nucleus. (E): After differentiation of embryonic
day-13.5 spinal cord NS, Mash1 cells (red) do not express GFAP (arrow, upper photograph) or O4 (middle photograph). Approximately 20% of
Mash1 cells expressed doublecortine (lower photograph). Scale bar  20 m. Abbreviations: bp, base pair; MW, molecular weight.
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jority of Map2ab and 3-tubulin neuronal cells were positive
for Olig2 (Fig. 5C). This was also observed with differentiated
NS derived from embryonic striatum (Fig. 5D). Regarding
Mash1 (Fig. 5E), approximately 20% of doublecortin cells (a
marker of young neurons [48]) were positive, whereas GFAP
and O4 cells were negative. These results demonstrate the
wide expression of some bHLH oligodendrogenic/neurogenic
factors in NS cells and their persistence in neuronal cells after
differentiation.
Olig2 Expression Is Induced by Cell Culture in CNS
and PNS Cells
The wide expression of Olig2 in embryonic spinal cord NS
contrasts with the small number of cells expressing this marker
in the ventral E13.5 spinal cord (Fig. 1A). This suggested that,
as for NG2, Olig2 expression may be induced under culture
conditions. To examine this possibility, E13.5 spinal cord cells
were cultured nonadherently in the presence of FGF2/EGF
growth factors, and Olig2 expression was monitored for 4 days.
As shown on Figure 1B, immediately after the seeding, less than
1% of cells were positive, whereas after 7 days, approximately
80% of the cultured cells displayed strong nuclear Olig2 stain-
ing. The vast majority of these olig2 cells expressed the radial
glial marker RC2 together with NG2 and A2B5 (not shown).
This strong and rapid increase in expression is indicative of
induction of the Olig2 bHLH protein in neural cells under cell
culture conditions. It was recently reported that the FGF2
growth factor used in the media could be responsible for this
effect [25, 49]. To definitively establish that Olig2 could be
induced by culture conditions in embryonic spinal cord cells, we
carefully dissected the dorsal part of E13.5 spinal cord, which is
devoid of Olig2 cells (Fig. 1A), and seeded cells in adherent
conditions with and without growth factors. One hour after
plating (day 0), not a single Olig2 cell could be detected by
immunofluorescence (Fig. 1C). However, after 1 and 2 days of
culture, Olig2 cells were readily detected in the condition with
FGF2EGF but not in the control condition (Fig. 1C and Fig.
S3A), even though the number of cells was comparable for the
two conditions (supplemental online Fig. S3). The same result
was obtained when the cells were grown on a nonadherent
substrate, and NS formation was observed (data not shown).
These Olig2 cells expressed A2B5 (100%) and the glial radial
marker RC2 (89%  3%, n  3) (supplemental online Fig. S4).
To obtain further insight into potential links between growth
factor stimulation and Olig2 expression, we tested the conse-
quences of reintroducing FGF2 and EGF in differentiated NS,
considering that Olig2 is not expressed by GFAP cells (Fig.
5C). Notably, after NS differentiation, GFAP cells never ex-
pressed nestin (supplemental online Fig. S5) but approximately
30% of them expressed vimentin (supplemental online Fig. S5).
This indicates that NS-derived astrocytes have various degrees
of immaturity. After 4 days of differentiation without growth
factors, FGF2 and/or EGF were added again and Olig2 expres-
sion was monitored by immunofluorescence. Surprisingly,
within 24 hours, almost 100% of GFAP (n  3) cells displayed
a strong Olig2 nuclear staining (Fig. 1D). This was observed
with each of the growth factors added separately or in combi-
nation (not shown).
FGF signaling has recently been implicated in the deregu-
lation of dorsoventral patterning [25] and the promotion of
radial glial identity of embryonic neural precursor cells [42].
The observed induction of NG2 and Olig2 in cells derived from
embryonic spinal cord argues for some deregulation occurring
in culture. To obtain further insight into this issue, we examined
the expression of the radial glial marker RC2 and of Olig2 in
cells derived from E13.5 PNS (dorsal root ganglia [DRG]). An
immunofluorescence analysis carried out on E13.5 slices indi-
cated the absence of Olig2 cells and RC2 in DRG (Fig. 1A,
1E). This absence of Olig2 or RC2 cells was also confirmed
in acutely dissociated cells from E13.5 DRG. We then cultured
acutely dissociated PNS cells nonclonally in NS media contain-
ing FGF2 and EGF. Extra precautions were taken during PNS
dissection to avoid contamination with CNS cells (see the pro-
tocol in the supplemental online data and supplemental online
Fig. S6). After 10 days, 83.6%  4.3% (n  5) and 89.7% 
4.7% (n  4) of cells expressed RC2 and Olig2, respectively
(Fig. 1F). This indicates an induction of these two markers in
PNS cells. Remarkably, after reseeding these cells at clonal
density, few NS were observed (0.01% of seeded cells). These
NS have a phenotype comparable with CNS NS (i.e., expression
of the radial glial marker RC2 together with NG2, A2B5, and
Olig2 markers) (Fig. 1G). They also express BLBP and GLAST
(data not shown). On differentiation, these NS generate 3-
tubulin neurons, GFAP cells, and CNPase cells morpho-
logically indistinguishable from those derived from CNS-de-
rived NS (data not shown). The generated neurons did not
express the marker peripherin as would be expected for PNS-
derived precursor cells (not shown). As expected, these NS also
generated smooth-muscle actin (SMA) cells after differentia-
tion (Fig. 1H), but surprisingly, such cells were also observed at
a similar abundance after differentiation of E13.5 spinal cord NS
(Fig. 1H).
Mash1 and Olig2 Are Not Sufficient to Induce NG2
in a Neural Precursor Cell Line
Mash1 expression was recently reported to be induced in neural
precursor cells by FGF2 and EGF [24]. Because both expres-
sions of the Olig2/Mash1 bHLH genes and NG2 seemed to be
under the influence of the growth factors, we investigated
whether Olig2 and Mash1 overexpression would be able to
trigger NG2 expression in a neural precursor cell line. For that,
we used a conditionally immortalized NSC line (MHP36) de-
rived from the embryonic hippocampus, which generates glial
and neuronal cells on differentiation in vitro and in vivo [28].
Immunodetection revealed that native MHP36 cells were neg-
ative for PDGFR-, Olig2, and Mash1 and very few cells were
NG2 (data not shown). MHP36 cells were transfected in the
nonimmortalizing conditions to eliminate expression of the on-
coprotein SV40 TAg, with mouse Olig2 and Mash1 expression
plasmids, and then were examined 48 hours later for Olig2,
Mash1, and NG2 or PDGFR- expression by triple-labeling. As
shown in Figure 1I, double-transfected cells expressing Olig2
and Mash1 were NG2. They did not express PDGFR- either
(data not shown). The same results were obtained with cells
transfected with Olig2 or Mash1 separately. These results indi-
cate that Olig2 and Mash1 bHLH proteins appear not to be
sufficient to trigger the expression of NG2 and PDGFR- in the
MHP36 neural precursor cell line.
DISCUSSION
Here, we report new data on neural precursor cells cultured as
NS. We observed that NS derived from several adult and em-
bryo regions contain cells with a striking phenotype in which
radial glia markers (RC2, BLBP, and GLAST) are coexpressed
with markers typical of the oligodendrocyte lineage (A2B5,
PDGFR-, NG2, and Olig2). After differentiation, the latter
remain principally expressed by neuronal cells. Using cytom-
etry, we showed that in growing NS, the small population of
multipotential self-renewing NS-forming cells are A2B5
NG2. However, we demonstrated that NSC in the embryonic
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spinal cord were initially NG2 but acquired this marker in
vitro. NG2 and Olig2 were found to be rapidly induced by cell
culture conditions in neural precursor cells, and Olig2 expres-
sion was also induced in astrocytes and PNS cells after EGF/
FGF treatment. However, Olig2 by itself, or in combination with
Mash1, did not appear to be sufficient to induce NG2 expression
in a multipotent neural cell line. These data are summarized on
Figure 6.
NS is a widely used model for the expansion and study of
neural precursor cells in vitro. NS have also been extensively
used for cellular therapy of neurodegenerative and demyelinat-
ing diseases. However, both the identity of cells that initiate NS
and cells that compose NS are still poorly defined. We and
others have reported that NS are composed of radial glial
cell-like expressing GLAST, RC2, and BLBP [14, 16]. The
observed coexpression of these markers with NG2 was unex-
pected because, in vivo, radial glial cells are largely NG2 [39,
44]. As indicated by our cytometric analysis, these NG2 radial
glial cells were in fact derived from NG2 NSC in embryonic
spinal cord. The identity of these cells remains unclear. Radial
glial cells are now considered to be the main CNS neuronal
progenitors at the embryonic stage [17], and in the neonatal
ventricular wall or in the ventral region of E14.5 forebrain
hemispheres, radial glial cells can generate NS [42, 50]. How-
ever, whether these cells form NS when taken from the embry-
onic spinal cord has not been established. In addition, NS
culture conditions induce BLBP expression in neural precursor
cells [16] or RC2 in PNS cells (Fig. 1F). Thus, whether the
NG2/RC2/BLBP cells observed in NS are derived from
spinal cord NG2 radial glial cells or from another NG2 cell
type remains to be established. With regard to A2B5, because
A2B5 cells are widely present in E13.5 embryonic spinal cord
(our data and [39]), we cannot exclude the possibility that NS
are derived from resident A2B5 cells. However, A2B5 has
been shown to be upregulated by FGF2 and EGF in culture [51]
and induced in cortical BLBP cells in culture [52]. In addition,
rodent E13.5 A2B5 cells are restricted to the glial lineage and
are not multipotent, even after FGF treatment [53]. Thus, it is
plausible that, like NG2, NS-forming cells may acquire A2B5 in
vitro.
Although NS appear phenotypically homogenous, only a
small fraction of the cells they contain are able to form new NS.
The identity of this NS-forming subpopulation is still largely
unknown. Only recently, Hoechst-based cell sorting (side pop-
ulation method) has allowed purification of these cells [54].
After four passages, our cytometric analysis showed that NS-
forming cells are mostly, if not all, NG2 A2B5, thus they do
not differ from the bulk of NS cells for these markers. Because
these cells are initially derived from NG2 cells, this indicates
that a phenotypic transition of multipotential self-renewing NS-
forming cells from NG2 to NG2 is likely to occur in vitro
(Fig. 6). It remains to be established whether this process occurs
by direct conversion of the NG2 cells into NG2 cells or by
production of NG2 cells from NG2 cells by asymmetric
division (Fig. 6). The above data argue for the existence of a
diversity of NSC displaying several phenotypes, including cell
surface molecules. As observed in vitro, it is likely that the
phenotype of NSC changes during CNS development.
After NS differentiation, we observed that A2B5,
PDGFR-, NG2, and Olig2 remained expressed by neuronal
cells whereas glial cells were largely negative (except for a
fraction of the oligodendrocytes which remains Olig2) (Fig.
6). Numerous in vitro studies have used these markers to iden-
tify cells that belong to the oligodendrocyte lineage; however,
our data together with other studies clearly indicate that these
markers label a variety of cell types, including NS-forming
Figure 6. Schematic summary of findings. In E13.5 embryo spinal cord, neural stem cells are initially NG2. When placed in culture, these cells
could be directly converted into NG2 cells. Alternatively, they could generate new NG2 neural stem cells by asymmetric division. After several
passages, multipotential self-renewing neurospheres (NS)-forming cells are mainly NG2 in vitro. These cells generate NS composed mainly of radial
glia cells expressing NG2, A2B5, PDGFR-, Sox9, and Olig2. A fraction of these cells (1%–10%) are able to form new multipotential passageable
NS after dissociation and replating. After growth factor removal and adhesion, NS cells differentiate into glial cells and neurons. These latter still
express NG2, A2B5, PDGFR-, and Olig2. Reintroduction of FGF2/EGF in the media induces Olig2 expression in GFAP cells and provokes
formation of new multipotential passageable NS [15]. Abbreviations: CNS, central nervous system; EGF, epidermal growth factor; FGF2, fibroblast
growth factor 2; GFAP, glial fibrillary acidic protein.
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cells, radial glia, and neurons. Thus, care must be taken when
interpreting their presence, especially in vitro. Astrocytes de-
rived from NS lack A2B5 expression and thus may be consid-
ered as type I astrocytes [55]. However, given that these GFAP
cells were derived from NS radial glia cells coexpressing A2B5,
PDGFR-, NG2, and Olig2, one can infer that these markers are
downregulated on astrocytic differentiation. Their persistence,
and in particular that of Olig2, in neuronal cells is really in-
triguing. Their morphology suggests that these cells are proba-
bly immature. These neurons may be related to the A2B5
3-tubulin cells identified in the E12.5 mouse neural tube
[56], to young NG2 neurons described in the mouse neocortex,
hippocampus, and subventricular zone [11, 57, 58], or to Olig2
neurons recently observed in fetal human CNS [59].
What are the mechanisms by which embryonic spinal cord
cells and NS-forming cells acquire NG2 in vitro? As for NG2,
the Olig2 bHLH gene was found to be induced in culture. After
differentiation, Olig2 was also expressed in NG2 neurons but
not in NG2 astrocytes. We thus tested whether forced expres-
sion of Olig2 was sufficient to trigger the expression of NG2
gene in a readily transfectable multipotent neural cell line
(MHP36). However, we found that in these cells, Olig2 alone, or
in combination with another cell-culture induced [24] bHLH
factor (Mash1), did not induce NG2 expression. Although the
MHP36 cell context is undoubtedly different from that of em-
bryonic spinal cord cells, this analysis indicates that Olig2 is not
sufficient by itself and that other transcription factors are prob-
ably necessary for NG2 activation in neural precursor cells. This
is further demonstrated by the Olig1/2 double-knockout mice,
which lead to a loss of oligodendrocytes with preservation of
NG2 expression [60], and thus a direct role of Olig bHLH genes
in NG2 expression is unlikely. As observed in neocortical cul-
tures, the acquisition of NG2 by Olig2 cells may require
coactivation by mitogen-activated protein kinase and phospha-
tidylinositol-3 kinases [43].
While this study was in progress, the growth factor FGF2
used in the medium was shown to be involved in the induction
of Olig2 in neural precursor cells [24, 25, 43, 49]. Olig2 factor
was found to play a role in NS self-renewal as well as in their
differentiation into neurons and oligodendrocytes [24]. FGF2 is
also used for promoting Olig2 and PDGFR- expression in
embryoid body derived from mouse embryonic stem cells [61].
We extended these observations by showing that Olig2 can be
induced in E13.5 embryonic dorsal spinal cord and in PNS cells
cultured in NS media. We also made the striking observation
that Olig2 is also rapidly expressed in NS-derived GFAP
astrocytes treated by FGF2. Because Olig2 protein was not
observed in the cytoplasm of nontreated astrocytes, it is unlikely
that the strong nuclear Olig2 staining we detected after the
cytokine treatment was due to a change of localization of the
protein as recently reported [62]. EGF treatment of GFAP cells
also induced strong Olig2 expression. The similar effects of
FGF2 and EGF are likely to arise from the vast overlap of their
signaling pathways [63]. The induction of Olig2 in NS-derived
GFAP cells may be related to their immature state given that
approximately 30% of these cells express vimentin. It would be
interesting to see whether astrocytes derived from adult CNS
also express Olig2 when treated with growth factors.
These data indicate that several types of mitogenic factors
have an influence on the expression on bHLH proteins that are
known to play crucial roles in governing cell fate. It is well
known that in addition to being mitogenic factors, at least some
members of the FGF family are endowed with morphogenetic
properties [64]. This appears to be achieved to some extent by
repressing other morphogens such as bone morphogenetic pro-
teins (BMP) [65]. It has been recently proposed that oligoden-
drocytes can be derived from dorsal spinal cord independently
of sonic hedgehog signaling by evasion from dorsal BMP-
inhibiting activities [66–68]. The addition of a BMP inhibitor
(noggin) promotes the formation of Olig2 cells from dorsal
spinal cord cells in culture [66]. We recently reported that in the
embryonic spinal cord NS, growth factors have a profound
effect on the expression of endogenous BMPs, notably by re-
pressing BMP4/6 [15]. It is thus tempting to speculate that FGF2
promotes Olig2 expression partly by inhibiting endogenous
BMPs that otherwise might provoke bHLH protein degradation
[69].
As recently reported by others [70], NS could also be
obtained from embryonic PNS. We found that these NS exhibit
a phenotype comparable with CNS NS. Although we cannot
absolutely exclude contamination from adjacent CNS, this is
unlikely considering the dissecting protocol we used. As ex-
pected for PNS precursor cells, these NS give rise to cells
expressing SMA, as also observed previously [70]. However,
such cells were also obtained from E13.5 embryonic spinal cord
NS. SMA cells have also been observed after differentiation of
embryonic CNS stem cells derived from several regions and
from adult subventricular zone cells [71, 72]. Their presence
appears to be linked to a CNS/neural crest transition due to
BMP/FGF2 signaling or low-density culture conditions. The
generation of SMA cells may thus represent an additional
aspect of deregulation of CNS precursor cells cultured under NS
conditions. The high level of endogenous BMP7 detected in
embryonic spinal cord NS [15] may be implicated in this de-
regulation.
In conclusion, our results provide additional support for the
emerging idea that culture conditions modify NSC fate and
phenotype. This is probably due to the inherent plasticity of
stem cells. This might first appear as an obstacle for developing
cellular biotherapies targeted at treating diseases in which spe-
cific types of neurons are affected. Yet it seems that these
modifications are not irreversible because, in vitro, the use of
different culture conditions or morphogens can direct stem cells
to generate specific types of neurons (for instance [73]). The
strong expression of NG2 by NS cells could raise concern on the
use of these cells for transplantation purposes. In fact, NG2 is a
chondroitin sulfate proteoglycan that has been described as one
of the main inhibitory molecules for axon growth present in the
glial scar after CNS lesions. It appears to be obstructive to
axonal regrowth by inducing growth cone collapse [74]. How-
ever, given that after in vitro differentiation, NS mainly generate
astrocytes that do not express NG2, it is likely that on trans-
plantation, a similar downregulation of NG2 expression occurs.
Alternatively, it is possible that NG2 has a positive influence on
the therapeutic effects observed with NS cell transplantation.
Actually, NG2 is necessary for PDGFR- receptor signaling
[75], and both NG2 and PDGFR- have been shown to play an
important role in the migration of several cell types [44, 76].
Thus, their expression in NS cells may participate in the remark-
able capacity of these cells to migrate in vitro and in vivo.
Moreover, NG2 binds several molecules, including cytokines
(FGF2, platelet-derived growth factor, and angiostatin) and ex-
tracellular cellular matrix molecules (collagen, tenascin, and
laminin) [77], that could help NS cell survival in the lesioned
tissue.
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